The primary tumour volume progression data revealed a slower growth rate of osteosarcoma derived from sh-NEAT1-transfected U2OS cells than tumours derived from sh-NC-transfected U2OS cells (Fig. 7c; p < 0.01 at day 14, 21, 28, 35, 42, respectively). Here, NEAT1 is linked to osteosarcoma.